Health · 57 views
New Zealand drugs regulator approves use of MDMA to treat severe PTSD
New Zealand decision follows Australian approval in 2023 of psychedelics to treat PTSD and treatment-resistant depression Two psychiatrists in New Zealand won approval on Friday to prescribe pharmaceutical-grade MDMA to people with severe…
AI Summary
Two psychiatrists in New Zealand received approval on Friday to prescribe pharmaceutical‑grade MDMA to patients with severe post‑traumatic stress disorder. The decision follows Australia’s 2023 approval of psychedelics for PTSD and treatment‑resistant depression.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Perimenopause is everywhere. How do you know if you’re in it? – podcastContinue reading
- Exploring the potential of immunotherapy in early-stage triple-negative breast cancerContinue reading
- Hemoglobin component heme shown to inhibit enzyme that helps dissolve blood clotsContinue reading
- How dismissed symptoms can push patients to breaking pointContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow